Skip to main content
. Author manuscript; available in PMC: 2023 Jun 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2022 May 2;445:116043. doi: 10.1016/j.taap.2022.116043

Fig. 1.

Fig. 1.

Effect of pre-treatment with deferoxamine (DFO) on APAP-induced liver injury. Mice were injected with 200 mg/kg DFO 1 h before 300 mg/kg APAP (i.p.). Blood and liver tissue were collected at 6 h after APAP. (A) Plasma alanine amino transferase (ALT) activities. (B) H&E-stained liver sections. (C) Quantification of areas of necrosis. Bars represent mean ± SEM for n = 5 mice. *p < 0.05 compared to APAP.